Rabbit Recombinant Monoclonal QPRT antibody. Carrier free. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
IP | IHC | WB | ICC/IF | Flow Cyt (Intra) | |
---|---|---|---|---|---|
Human | Tested | Not recommended | Tested | Not recommended | Tested |
Mouse | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Involved in the catabolism of quinolinic acid (QA).
Nicotinate-nucleotide pyrophosphorylase [carboxylating], Quinolinate phosphoribosyltransferase [decarboxylating], QAPRTase, QPRTase, QPRT
Rabbit Recombinant Monoclonal QPRT antibody. Carrier free. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ab249663 is the carrier-free version of Anti-QPRT antibody [EPR11941(B)] ab171944.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
QPRT also known as Nicotinate-nucleotide pyrophosphorylase [carboxylating] or Quinolinate phosphoribosyltransferase functions as an important enzyme in the kynurenine pathway a metabolic pathway leading to the production of nicotinamide adenine dinucleotide (NAD+). The enzyme catalyzes the conversion of quinolinate to nicotinic acid mononucleotide. QPRT has a molecular mass of approximately 34 kDa. It is expressed in various tissues most notably in the liver kidney and brain.
QPRT influences the synthesis of NAD+ which is essential for cellular redox reactions and energy metabolism. The enzyme operates as a monomer and does not typically form part of a larger complex. However its activity is important in maintaining NAD+ levels which can impact a wide range of cellular processes such as DNA repair signal transduction and metabolism.
QPRT holds a significant role in the kynurenine pathway and NAD+ biosynthesis. This pathway includes several enzymes such as kynurenine 3-monooxygenase and kynureninase which collaboratively contribute to the degradation of tryptophan ultimately affecting the levels of important coenzymes and neurotransmitters. The NAD+ biosynthesis pathway involving QPRT also interacts with pathways for ATP generation connecting with other metabolic processes.
QPRT's malfunction links to neurological disorders such as Alzheimer's disease due to its role in NAD+ metabolism and potential effects on neuronal health and energy supply. Additionally alterations in QPRT activity have associations with liver diseases considering its expression and function in metabolic pathways within hepatic tissues. Interaction with proteins like kynurenine aminotransferase highlights its involvement in maintaining metabolic balance within these conditions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-QPRT antibody [EPR11941(B)] ab171944, the same antibody clone in a different buffer formulation.
Lane 1 Wild-type HAP1 cell lysate (20 μg)
Lane 2 QPRT knockout HAP1 cell lysate (20 μg)
Lane 3 HepG2 cell lysate (20 μg)
Lane 4 Human fetal brain cell lysate (20 μg)
Lanes 1 - 4 Merged signal (red and green). Green - Anti-QPRT antibody [EPR11941(B)] ab171944 observed at 35 kDa. Red - loading control, Anti-GAPDH antibody [6C5] - Loading Control ab8245, observed at 37 kDa.
Anti-QPRT antibody [EPR11941(B)] ab171944 was shown to specifically react with QPRT when QPRT knockout samples were used. Wild-type and QPRT knockout samples were subjected to SDS-PAGE. Anti-QPRT antibody [EPR11941(B)] ab171944 and Anti-GAPDH antibody [6C5] - Loading Control ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes: Western blot - Anti-QPRT antibody [EPR11941(B)] (Anti-QPRT antibody [EPR11941(B)] ab171944)
Predicted band size: 31 kDa
This data was developed using Anti-QPRT antibody [EPR11941(B)] ab171944, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-QPRT antibody [EPR11941(B)] (Anti-QPRT antibody [EPR11941(B)] ab171944) at 1/1000 dilution
Lane 1: Human fetal kidney tissue lysate at 10 µg
Lane 2: Human fetal liver tissue lysate at 10 µg
Lane 3: HepG2 cell lysate at 10 µg
Lane 4: HeLa cell lysate at 10 µg
Lane 5: Jurkat cell lysate at 10 µg
Lane 6: Human fetal heart tissue lysate at 10 µg
Developed using the ECL technique.
Predicted band size: 31 kDa
This data was developed using Anti-QPRT antibody [EPR11941(B)] ab171944, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of permeabilized Jurkat cells labeling QPRT with Anti-QPRT antibody [EPR11941(B)] ab171944 at 1/10 (red) or a rabbit IgG (negative) (green).
This data was developed using the same antibody clone in a different buffer formulation (Anti-QPRT antibody [EPR11941(B)] ab171944)
All lanes: Western blot - Anti-QPRT antibody [EPR11941(B)] (Anti-QPRT antibody [EPR11941(B)] ab171944) at 1/500 dilution
Lane 1: Wild-type HAP1 lysate at 20 µg
Lane 2: QPRT knock-out HAP1 lysate at 20 µg
Predicted band size: 31 kDa
This data was developed using the same antibody clone in a different buffer formulation (Anti-QPRT antibody [EPR11941(B)] ab171944)
Lane 1: Immunoprecipitation - Anti-QPRT antibody [EPR11941(B)] (Anti-QPRT antibody [EPR11941(B)] ab171944) at 1/1000 dilution
Lane 3: Immunoprecipitation - Anti-QPRT antibody [EPR11941(B)] (Anti-QPRT antibody [EPR11941(B)] ab171944) at 2 µg
All lanes: HAP1 cells
Observed band size: 31 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com